Cholesterol Buildup in Brain Presents New Target to Reduce Dementia Risk From Stroke

This shows a head being erased by a pencil eraserCyclodextrin, an FDA-approved drug, reduced cholesterol accumulation from broken down brain cells and inflammation in animal models. The findings point to a potential new therapy to reduce dementia following a stroke.